Insider Trades16 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Buy | DNTH | Adam M Veness | SVP, General Counsel and Sec. | 15,000 | $18.17 | $5.9B | -9.90% | +229.61% | $272.6K | +20.48% | — | Sell Now |
| Aug 7, 2026 | Sell | DNTH | Adam M Veness | SVP, General Counsel and Sec. | 40,000 | $64.16 | $5.9B | -9.90% | +229.61% | $2.6M | +0.00% | 10b5-1 | Sell Now |
| Aug 7, 2026 | Sell | DNTH | Marino Garcia | CEO AND PRESIDENT | 332,000 | $58.27 | $5.9B | -9.90% | +229.61% | $19.3M | +0.00% | 10b5-1 | Sell Now |
| Jul 9, 2026 | Sell | DNTH | Ryan Savitz | EVP, CFO & CBO | 62,498 | $61.40 | $5.9B | -9.90% | +229.61% | $3.8M | +0.00% | 10b5-1 | Sell Now |
| Jun 17, 2026 | Sell | DNTH | Adam M Veness | SVP, General Counsel and Sec. | 60,000 | $49.34 | $5.9B | -9.90% | +229.61% | $3.0M | +0.00% | 10b5-1 | Sell Now |
| Jun 1, 2026 | Sell | DNTH | Simrat Randhawa | EVP, Head of R&D | 53,060 | $54.74 | $5.9B | -9.90% | +229.61% | $2.9M | +0.00% | 10b5-1 | Sell Now |
| Apr 9, 2026 | Sell | DNTH | Ryan Savitz | EVP, CFO & CBO | 16,448 | $53.86 | $5.9B | -9.90% | +229.61% | $885.9K | +0.00% | 10b5-1 | Sell Now |
| Mar 31, 2026 | Sell | DNTH | Ryan Savitz | EVP, CFO & CBO | 228,734 | $47.37 | $5.9B | -9.90% | +229.61% | $10.8M | +0.00% | 10b5-1 | Sell Now |
| Mar 16, 2026 | Buy | DNTH | Marino Garcia | CEO AND PRESIDENT | 65,292 | $7.66 | $5.9B | -9.90% | +229.61% | $500.0K | +19.84% | — | Sell Now |
| Mar 12, 2026 | Sell | DNTH | Simrat Randhawa | EVP, Head of R&D | 67,660 | $49.82 | $5.9B | -9.90% | +229.61% | $3.4M | +0.00% | 10b5-1 | Sell Now |
| Mar 12, 2026 | Sell | DNTH | Edward Carr | CHIEF ACCOUNTING OFFICER | 87,364 | $50.97 | $5.9B | -9.90% | +229.61% | $4.5M | +0.00% | 10b5-1 | Sell Now |
| Mar 12, 2026 | Sell | DNTH | Marino Garcia | CEO AND PRESIDENT | 245,836 | $44.09 | $5.9B | -9.90% | +229.61% | $10.8M | +0.00% | 10b5-1 | Sell Now |
| Dec 4, 2025 | Sell | DNTH | Ryan Savitz | CFO & CBO | 40,000 | $26.81 | $5.9B | -9.90% | +229.61% | $1.1M | +0.00% | 10b5-1 | Sell Now |
| Nov 13, 2025 | Sell | DNTH | Simrat Randhawa | EVP, Head of R&D | 393,076 | $26.40 | $5.9B | -9.90% | +229.61% | $10.4M | +0.00% | 10b5-1 | Sell Now |
| Sep 9, 2025 | Sell | DNTH | Ryan Savitz | CFO & CBO | 40,000 | $21.72 | $5.9B | -9.90% | +229.61% | $868.8K | +0.00% | 10b5-1 | Sell Now |
| Sep 21, 2023 | Buy | DNTH | Simrat Randhawa | Chief Medical Officer | 4,000 | $13.20 | $5.9B | -9.90% | +229.61% | $52.8K | +200.00% | — | Sell Now |